Medical Device News Magazine

Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Graham Belgrave, Senior Vice President of European Operations at Advanced Clinical, has been recognized by PharmaVOICE magazine as a distinguished leader on the 2021 PharmaVOICE 100 list.

 

As one of the first European hires at Advanced Clinical in 2017, Graham Belgrave built the company’s infrastructure and functional teams outside of North America, contributing to the company’s fast growth and development in regions outside of North America. Under his leadership, Advanced Clinical has grown tremendously from having minimal presence in Europe to now having 10 country offices and a European team comprised of tenured and experienced industry professionals that are dedicated to serving clients.

 

“The amazingly powerful culture of servant leadership that permeates through Advanced Clinical is, in my opinion of 37 years in the pharmaceutical industry, truly unique,” said Belgrave. “It empowers, supports, and inspires in equal measure. I am fortunate to be in a position to fully embrace and live this ‘way of working’ and am humbled to be awarded this honor, surrounded as I am by such a stellar group of leaders.”

At Advanced Clinical, and from previous organizations, Belgrave serves as a mentor to several colleagues, where he challenges them to think outside of the box and take risks. From past leadership accomplishments to serving as a member of several scientific and pharmaceutical associations, Belgrave is most proud of his collaborations with his team and helping them to develop their skillsets.

PharmaVOICE 100 is an annual list established by PharmaVOICE magazine that recognizes individuals whose inspiration, motivation, and outstanding leadership have made an impact to the life sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers and are selected based on specific criteria as well as involvement in community and philanthropic efforts. The honorees represent a broad cross-section of industry leaders.

The July/August special issue of PharmaVOICE magazine is available for viewing online. To learn more about Belgrave’s leadership and accomplishments, please visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”